Zeitschriftenartikel (67)
2020
Zeitschriftenartikel
Wegwarth, O., , , , , , , , , , , & Hertwig, R. (2020). Experiencing the risk of overutilising opioids among patients with chronic non-cancer pain in ambulatory care (ERONA): The protocol of an exploratory, randomised controlled trial. BMJ Open, 10, Article e037642. https://doi.org/10.1136/bmjopen-2020-037642
Zeitschriftenartikel
Wegwarth, O., Wagner, G. G., , & Hertwig, R. (2020). Assessment of German public attitudes toward health communications with varying degrees of scientific uncertainty regarding COVID-19. JAMA Network Open, 3(12), Article e2032335. https://doi.org/10.1001/jamanetworkopen.2020.32335
2019
Zeitschriftenartikel
Wegwarth, O., , , , , & (2019). Health-related preferences of older patients with multimorbidity: An evidence map. BMJ Open, 9, Article e034485. https://doi.org/10.1136/bmjopen-2019-034485
, , , , , , , , ,
Zeitschriftenartikel
Wegwarth, O., , , , & (2019). Health-related preferences of older patients with multimorbidity: The protocol for an evidence map. BMJ Open, 9, Article e029724. https://doi.org/10.1136/bmjopen-2019-029724
, , , , , , ,
Zeitschriftenartikel
McDowell, M. E., Gigerenzer, G., Wegwarth, O., & Rebitschek, F. G. (2019). Effect of tabular and icon fact box formats on comprehension of benefits and harms of prostate cancer screening: A randomized trial. Medical Decision Making, 39(1), 41–56. https://doi.org/10.1177/0272989X18818166
Zeitschriftenartikel
Rebitschek, F. G., , , & Wegwarth, O. (2019). Do cancer risk and benefit-harm ratios influence women's consideration of risk-reducing mastectomy? A scenario-based experiment in five European countries. PLoS ONE, 14(6), Article e0218188. https://doi.org/10.1371/journal.pone.0218188
Zeitschriftenartikel
Rebitschek, F. G., , Lein, I., & Wegwarth, O. (2019). Epigenetic risk assessment of female cancers: Women's information needs and attitudes. Public Health Genomics, 22(1-2), 46–57. https://doi.org/10.1159/000501975
Zeitschriftenartikel
Wegwarth, O., , , & Rebitschek, F. G. (2019). Women's perception, attitudes, and intended behavior towards predictive epigenetic risk testing for female cancers in 5 European countries: A cross-sectional online survey. BMC Public Health, 19, Article 667. https://doi.org/10.1186/s12889-019-6994-8
2018
Zeitschriftenartikel
Prinz, R., , & Wegwarth, O. (2018). Alternative package leaflets improve people's understanding of drug side effects - A randomized controlled exploratory survey. PLoS ONE, 13(9), Article e0203800. https://doi.org/10.1371/journal.pone.0203800
,
Zeitschriftenartikel
Wegwarth, O. (2018). Brustkrebsfrüherkennung - Nutzen und Risiken richtig kommunizieren. Der Gynäkologe, 51(5), 370–379. https://doi.org/10.1007/s00129-018-4199-3
Zeitschriftenartikel
Wegwarth, O., & Gigerenzer, G. (2018). US gynecologists' estimates and beliefs regarding ovarian cancer screening's effectiveness 5 years after release of the PLCO evidence. Scientific Reports, 8, Article 17181. https://doi.org/10.1038/s41598-018-35585-z
Zeitschriftenartikel
Wegwarth, O., , , , , Lein, I., Rebitschek, F. G., & . (2018). What do European women know about their female cancer risks and cancer screening? A cross-sectional online intervention survey in five European countries. BMJ Open, 8, Article e023789. https://doi.org/10.1136/bmjopen-2018-023789
Zeitschriftenartikel
Wegwarth, O., Rebitschek, F. G., , , , , , , , , , , , , , , , & . (2018). Epigenome-based cancer risk prediction: Rationale, opportunities and challenges. Nature Reviews Clinical Oncology, 15(5), 292–309. https://doi.org/10.1038/nrclinonc.2018.30
, , , , , , , , 2017
Zeitschriftenartikel
Westram, A., Feufel, M., Gaissmaier, W., Wegwarth, O., & Gigerenzer, G. (2017). The phenomenology of the diagnostic process: A primary-care based survey. Medical Decision Making, 37(1), 27–34. https://doi.org/10.1177/0272989X16653401
, , , , ,
Zeitschriftenartikel
Wegwarth, O., Wagner, G. G., & Gigerenzer, G. (2017). Can facts trump unconditional trust? Evidence-based information halves the influence of physicians' non-evidence-based cancer screening recommendations. PLoS ONE, 12(8), Article e0183024. https://doi.org/10.1371/journal.pone.0183024
2016
Zeitschriftenartikel
McDowell, M., Rebitschek, F. G., Gigerenzer, G., & Wegwarth, O. (2016). A simple tool for communicating the benefits and harms of health interventions: A guide for creating a fact box. MDM Policy & Practice, 1, Article 2381468316665365. https://doi.org/10.1177/2381468316665365
2015
Zeitschriftenartikel
Prinz, R., Feufel, M. A., Gigerenzer, G., & Wegwarth, O. (2015). What counselors tell low-risk clients about HIV test performance. Current HIV Research, 13(5), 369–380. https://doi.org/10.2174/1570162X13666150511125200
Zeitschriftenartikel
Wegwarth, O. (2015). Medizinische Risikokommunikation: Nutzen und Schaden transparent kommunizieren. Forum: Das Offizielle Magazin der Deutschen Krebsgesellschaft e. V., 30(3), 208–213. https://doi.org/10.1007/s12312-015-1303-7
Zeitschriftenartikel
Wegwarth, O. (2015). Cancer survival rates: The CONCORD-2 study. The Lancet, 386(9992), 429–429. https://doi.org/10.1016/S0140-6736(15)61442-8
2014
Zeitschriftenartikel
Wegwarth, O. (2014). Transparent risk communication in cancer screening: Reveal when it's good and when it's not. Oncology Research and Treatment, 37(Suppl. 3), 6–7. https://doi.org/10.1159/000367912